The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Osteosarcoma Overview
Open accessAbstract
Osteosarcoma (OS) is the most common primary malignancy of bone and patients with metastatic disease or recurrences continue to have very poor outcomes. Unfortunately, little prognostic improvement has been generated from the last 20 years of research and a new perspective is warranted. OS is extremely heterogeneous in both its origins and manifestations. Although multiple associations have been made between the development of osteosarcoma and race, gender, age, various genomic alterations, and exposure situations among others, the etiology remains unclear and controversial. Noninvasive diagnostic methods include serum markers like alkaline phosphatase and a growing variety of imaging techniques including X-ray, computed tomography, magnetic resonance imaging, and positron emission as well as combinations thereof. Still, biopsy and microscopic examination are required to confirm the diagnosis and carry additional prognostic implications such as subtype classification and histological response to neoadjuvant chemotherapy. The current standard of care combines surgical and chemotherapeutic techniques, with a multitude of experimental biologics and small molecules currently in development and some in clinical trial phases. In this review, in addition to summarizing the current understanding of OS etiology, diagnostic methods, and the current standard of care, our group describes various experimental therapeutics and provides evidence to encourage a potential paradigm shift toward the introduction of immunomodulation, which may offer a more comprehensive approach to battling cancer pleomorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“Tumor-associated macrophages, although mostly thought of as being pro-tumorigenic [164], have been found to play a potentially significant role in preventing metastasis in high-grade OS [165].”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,786
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
A system for the surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1981) · PubMed · Cited by 1,001
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Self-citationRecurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752
Metastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
Biology and Therapeutic Advances for Pediatric Osteosarcoma
Marina, N., Gebhardt, M., Teot, L., & Gorlick, R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-422 · Cited by 671
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Second primary neoplasms in patients with retinoblastoma
Draper, G. J., Sanders, B. M., & Kingston, J. E. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.110 · Cited by 554
Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C., van den Berg, H., Brennan, B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30214-5 · Cited by 551
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
Rougraff, B. T., Simon, M. A., Kneisl, J. S., Greenberg, D. B., & Mankin, H. J. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199405000-00004 · Cited by 536
Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508
Osteosarcoma (Osteogenic sarcoma)
Picci, P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-6 · Cited by 505
Dorfman, H. D., & Czerniak, B. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v · Cited by 496
Radiation-induced sarcoma of bone
Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., & Shah, I. C. (1971) · Cancer · doi:10.1002/1097-0142(1971)28:5<1087::aid-cncr2820280502>3.0.co;2-f · Cited by 483
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
Geller, D. S., & Gorlick, R. G. (2010) · PubMed · Cited by 475
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.
Simon, M. A., Aschliman, M. A., Thomas, N., & Mankin, H. J. (1986) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198668090-00005 · Cited by 469
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456
Limb-Salvage Treatment Versus Amputation for Osteosarcoma of the Distal End of the Femur
Simon, M. A., Aschliman, M. A., Thomas, N., & Mankin, H. J. (2005) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.8712.cl · Cited by 452
Bacci, G., Ferrari, S., Bertoni, F., Ruggieri, P., Picci, P., Longhi, A., Casadei, R., Fabbri, N., Forni, C., Versari, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4016 · Cited by 438
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Prognostic factors in osteosarcoma: a critical review.
Davis, A. M., Bell, R. S., & Goodwin, P. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.2.423 · Cited by 424
Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0734 · Cited by 422
CTLA-4 blockade in tumor models: an overview of preclinical and translational research.
Grosso, J. F., & Jure‐Kunkel, M. (2013) · Europe PMC (PubMed Central) · Cited by 402
Ag, H., Rosen, G., & Marcove, R. C. (1977) · PubMed · Cited by 396
Osteogenic sarcoma with clinically detectable metastasis at initial presentation.
Meyers, P. A., Heller, G., Healey, J. H., Huvos, A., Applewhite, A., Sun, M., & LaQuaglia, M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.449 · Cited by 390
Initial Symptoms and Clinical Features in Osteosarcoma and Ewing Sarcoma*
WIDHE, B., & WIDHE, T. (2000) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200005000-00007 · Cited by 375
GM-CSF in inflammation and autoimmunity
Hamilton, J. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02260-3 · Cited by 373
Walkley, C. R., Qudsi, R., Sankaran, V. G., Perry, J. A., Gostissa, M., Roth, S. I., Rodda, S. J., Snay, E., Dunning, P., Fahey, F. H., et al. (2008) · Genes & Development · doi:10.1101/gad.1656808 · Cited by 373
Nash, G., Turner, L., Scully, M., & Kakkar, A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00789-1 · Cited by 366
Grignani, G., Palmerini, E., Dileo, P., Asaftei, S. D., D’Ambrosio, L., Pignochino, Y., Mercuri, M., Picci, P., Fagioli, F., Casali, P. G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr151 · Cited by 359
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Interferon-alpha in tumor immunity and immunotherapy
Belardelli, F., Ferrantini, M., Proietti, E., & Kirkwood, J. M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00022-3 · Cited by 337
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Bramwell, V. H., Burgers, M., Sneath, R., Souhami, R., van Oosterom, A. T., Voûte, P. A., Rouesse, J., Spooner, D., Craft, A. W., & Somers, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1579 · Cited by 313
Radiotherapy for local control of osteosarcoma
DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.051 · Cited by 306
Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.
Wittig, J. C., Bickels, J., Priebat, D. A., Jelinek, J. S., Kellar-Graney, K., Shmookler, B. M., & Malawer, M. M. (2002) · PubMed · Cited by 299
The many faces of osteosarcoma.
Murphey, M. D., Robbin, M. R., McRae, G. A., Flemming, D. J., Temple, H. T., & Kransdorf, M. J. (1997) · RadioGraphics · doi:10.1148/radiographics.17.5.9308111 · Cited by 287
Mialou, V., Philip, T., Kalifa, C., Perol, D., Gentet, J., Marec‐Berard, P., Pacquement, H., Chastagner, P., Defaschelles, A., & Hartmann, O. (2005) · Cancer · doi:10.1002/cncr.21263 · Cited by 286
Tumor size and prognosis in aggressively treated osteosarcoma.
Bieling, P., Rehan, N., Winkler, P., Helmke, K., Maas, R., Fuchs, N., Bielack, S., Heise, U., Jurgens, H., Treuner, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.848 · Cited by 275
Picci, P., Bacci, G., Campanacci, M., Gasparini, M., Pilotti, S., Cerasoli, S., Bertoni, F., Guerra, A., Capanna, R., Albisinni, U., et al. (1985) · Cancer · doi:10.1002/1097-0142(19851001)56:7<1515::aid-cncr2820560707>3.0.co;2-6 · Cited by 274
Andrews, E. B., Gilsenan, A. W., Midkiff, K., Sherrill, B., Wu, Y., Mann, B. H., & Masica, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1768 · Cited by 272
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Berman, S. D., Calo, E., Landman, A. S., Danielian, P. S., Miller, E. S., West, J. C., Fonhoue, B. D., Caron, A., Bronson, R., Bouxsein, M. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805462105 · Cited by 266
IL-28 and IL-29: Newcomers to the interferon family
Uzé, G., & Monneron, D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.008 · Cited by 260
Bacci, G., Bertoni, F., Longhi, A., Ferrari, S., Forni, C., Biagini, R., Bacchini, P., Donati, D., Manfrini, M., Bernini, G., et al. (2003) · Cancer · doi:10.1002/cncr.11456 · Cited by 253 · cited 1×
“While many subtypes exist and correlate specifically to corresponding chemotherapeutic responses [107], the unifying histological feature is the presence of osteoid-producing malignant cells [105].”
BackgroundMartin, J. W., Squire, J. A., & Zielenska, M. (2012) · Sarcoma · doi:10.1155/2012/627254 · Cited by 252
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Age-specific Fluoride Exposure in Drinking Water and Osteosarcoma (United States)
Bassin, E. B., Wypij, D., Davis, R. B., & Mittleman, M. A. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0500-6 · Cited by 249
Chou, A. J., Kleinerman, E. S., Krailo, M. D., Chen, Z., Betcher, D. L., Healey, J. H., Conrad, E. U., Nieder, M. L., Weiner, M. A., Wells, R. J., et al. (2009) · Cancer · doi:10.1002/cncr.24566 · Cited by 245
Self-citationEbb, D., Meyers, P., Grier, H., Bernstein, M., Gorlick, R., Lipshultz, S. E., Krailo, M., Devidas, M., Barkauskas, D. A., Siegal, G. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4546 · Cited by 243
Host related risk factors for canine osteosarcoma
Ru, G., Terracini, B., & Glickman, L. T. (1998) · The Veterinary Journal · doi:10.1016/s1090-0233(98)80059-2 · Cited by 243
Moriarity, B. S., Otto, G. M., Rahrmann, E. P., Rathe, S. K., Wolf, N. K., Weg, M. T., Manlove, L. A., LaRue, R. S., Temiz, N. A., Molyneux, S. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3293 · Cited by 240
BLOOM, D. (1954) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1954.02050100756008 · Cited by 239
Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D. J., & Rao, B. N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1602::aid-cncr31>3.0.co;2-r · Cited by 215
Franzius, C., Daldrup-Link, H. E., Sciuk, J., Rummeny, E. J., Bielack, S., Jürgens, H., & Schober, O. (2001) · Annals of Oncology · doi:10.1023/a:1011111322376 · Cited by 211
Frequency and structure of p53 rearrangements in human osteosarcoma.
Miller, C. W., Aslo, A., Tsay, C., Slamon, D. J., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. C., & Koeffler, H. P. (1990) · PubMed · Cited by 210
Lussier, D. M., Johnson, J. L., Hingorani, P., & Blattman, J. N. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0067-z · Cited by 206
Toguchida, J., Ishizaki, K., Sasaki, M. S., Ikenaga, M., Sugimoto, M., Kotoura, Y., & Yamamuro, T. (1988) · PubMed · Cited by 206
Genome-wide association study identifies two susceptibility loci for osteosarcoma
Savage, S. A., Mirabello, L., Wang, Z., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Flanagan, A. M., Tirabosco, R., Andrulis, I. L., Wunder, J. S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2645 · Cited by 202
ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
Onda, M., Matsuda, S., Higaki, S., Iijima, T., Fukushima, J.-I., Yokokura, A., Kojima, T., Horiuchi, H., Kurokawa, T., & Yamamoto, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<71::aid-cncr13>3.0.co;2-5 · Cited by 201
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Feugeas, O., Guriec, N., Babin-Boilletot, A., Marcellin, L., Simon, P., Babin, S., Thyss, A., Hofman, P., Terrier, P., Kalifa, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.467 · Cited by 199
Pappo, A. S., Vassal, G., Crowley, J. J., Bolejack, V., Hogendoorn, P. C. W., Chugh, R., Ladanyi, M., Grippo, J. F., Dall, G., Staddon, A. P., et al. (2014) · Cancer · doi:10.1002/cncr.28728 · Cited by 197
18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
Costelloe, C. M., Macapinlac, H. A., Madewell, J. E., Fitzgerald, N. E., Mawlawi, O. R., ROHREN, E. M., Raymond, A. K., Lewis, V. O., Anderson, P. M., Bassett, R. L., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058461 · Cited by 196
Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
PosthumaDeBoer, J., Witlox, M. A., Kaspers, G. J. L., & van Royen, B. J. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9384-x · Cited by 194
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Le Vu, B., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<370::aid-ijc11>3.0.co;2-c · Cited by 193
Prognostic factors and outcomes for osteosarcoma: An international collaboration
Pakos, E. E., Nearchou, A. D., Grimer, R. J., Koumoullis, H. D., Abudu, A., Bramer, J. A. M., Jeys, L. M., Franchi, A., Scoccianti, G., Campanacci, D., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.005 · Cited by 193
Overholtzer, M., Rao, P. H., Favis, R., Lu, X.-Y., Elowitz, M. B., Barany, F., Ladanyi, M., Gorlick, R., & Levine, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934852100 · Cited by 193
Ferrari, S., Ruggieri, P., Cefalo, G., Tamburini, A., Capanna, R., Fagioli, F., Comandone, A., Bertulli, R., Bisogno, G., Palmerini, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4420 · Cited by 192
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
Sæter, G., Høie, J., Stenwig, A. E., Johansson, A., Hannisdal, E., & Solheim, Ø. P. (1995) · Cancer · doi:10.1002/1097-0142(19950301)75:5<1084::aid-cncr2820750506>3.0.co;2-f · Cited by 190
Alterations of thep53, Rb andMDM2 genes in osteosarcoms
Miller, C. W., Aslo, A., Won, A., Tan, M., Lampkin, B., & Koefflar, H. P. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213553 · Cited by 190
Hudson, M., Jaffe, M. R., Jaffe, N., Ayala, A., Raymond, A. K., Carrasco, H., Wallace, S., Murray, J., & Robertson, R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.12.1988 · Cited by 189
Osteosarcoma over the age of forty
Grimer, R. J., Cannon, S. R., Taminiau, A. M., Bielack, S., Kempf-Bielack, B., Windhager, R., Dominkus, M., Saeter, G., Bauer, H., Meller, I., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00478-1 · Cited by 188
Sarcomas of bone complicating osteitis deformans (Pagetʼs disease): Fifty yearsʼ experience
Wick, M. R., McLeod, R. A., Siegal, G. P., Greditzer, H. G., & Unni, K. K. (1981) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198101000-00008 · Cited by 183
Tsuchiya, T., Sekine, K.-I., Hinohara, S.-I., Namiki, T., Nobori, T., & Kaneko, Y. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00255-1 · Cited by 179
Of mice and men: divergent risks of teriparatide-induced osteosarcoma
Subbiah, V., Madsen, V. S., Raymond, A. K., Benjamin, R. S., & Ludwig, J. A. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1004-0 · Cited by 177
The role of cytokines in the epithelial cancer microenvironment
Wilson, J., & Balkwill, F. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0419 · Cited by 174
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII
Smeland, S., Müller, C., Alvegard, T. A., Wiklund, T., Wiebe, T., Björk, O., Stenwig, A. E., Willén, H., Holmström, T., Follerås, G., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00747-5 · Cited by 166
Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward, W. G., Mikaelian, K. A., Dorey, F. J., Mirra, J. M., Sassoon, A., Holmes, E. C., Eilber, F. R., & Eckardt, J. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.9.1849 · Cited by 157
Kleinerman, E. S., Jia, S. F., Griffin, J., Seibel, N. L., Benjamin, R. S., & Jaffe, N. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1310 · Cited by 157
Self-citationBacci, G., Longhi, A., Forni, C., Setola, E., & Ferrari, E. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00546-x · Cited by 155
Resection of recurrent pulmonary metastases in patients with osteosarcoma
Briccoli, A., Rocca, M., Salone, M., Bacci, G., Ferrari, S., Balladelli, A., & Mercuri, M. (2005) · Cancer · doi:10.1002/cncr.21369 · Cited by 153
Hawkins, D. S., & Arndt, C. A. S. (2003) · Cancer · doi:10.1002/cncr.11799 · Cited by 147
Kleinerman, E. S., Erickson, K. L., Schroit, A. J., Fogler, W. E., & Fidler, I. J. (1983) · PubMed · Cited by 141
Self-citation“Skip” metastases in osteosarcoma
Enneking, W. F., & Kagan, A. (1975) · Cancer · doi:10.1002/cncr.2820360937 · Cited by 139
Bacci, G., Ferrari, S. M., Mercuri, M., Bertoni, F., Picci, P., Manfrini, M., Gasbarrini, A., Forni, C., Cesari, M., & Campanacci, M. (1998) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679809000921 · Cited by 139
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone, M., Kalifa, C., Rodary, C., Raquin, M. A., Valteau‐Couanet, D., & Lemerle, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2614 · Cited by 137
Bacci, G., Briccoli, A., Longhi, A., Ferrari, S., Mercuri, M., Faggioli, F., Versari, M., & Picci, P. (2005) · Acta Oncologica · doi:10.1080/02841860500327503 · Cited by 134
Bertrand, T. E., Cruz, A. A., Binitie, O. T., Cheong, D., & Letson, D. G. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4359-x · Cited by 132
Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Gökgöz, N., Wunder, J. S., Mousses, S., Eskandarian, S., Bell, R. S., & Andrulis, I. L. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3 · Cited by 131
Chou, A. J., Merola, P. R., Wexler, L. H., Gorlick, R. G., Vyas, Y. M., Healey, J. H., LaQuaglia, M. P., Huvos, A. G., & Meyers, P. A. (2005) · Cancer · doi:10.1002/cncr.21417 · Cited by 131
Biermann, J. S., Adkins, D. R., Agulnik, M., Benjamin, R. S., Brigman, B. E., Butrynski, J. E., Cheong, D., Chow, W. A., Curry, W. T., Frassica, D. A., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0088 · Cited by 129
Zhou, H., Randall, R. L., Brothman, A. R., Maxwell, T. M., Coffin, C. M., & Goldsby, R. E. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200301000-00007 · Cited by 125
Osteogenic sarcoma of the extremity with detectable lung metastases at presentation
Bacci, G., Mercuri, M., Briccoli, A., Ferrari, S., Bertoni, F., Donati, D. M., Monti, C., Zanoni, A., Forni, C., & Manfrini, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2<245::aid-cncr7>3.0.co;2-j · Cited by 122
Surgical treatment for osteosarcoma.
Springfield, D. S., Schmidt, R., Graham‐Pole, J., Marcus, R. B., Spanier, S. S., & Enneking, W. F. (1988) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198870080-00002 · Cited by 113
ErbB2 expression is correlated with increased survival of patients with osteosarcoma
Akatsuka, T., Wada, T., Kokai, Y., Kawaguchi, S., Isu, K., Yamashiro, K., Yamashita, T., Sawada, N., Yamawaki, S., & Ishii, S. (2002) · Cancer · doi:10.1002/cncr.10360 · Cited by 112
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Pradelli, E., Karimdjee-Soilihi, B., Michiels, J., Ricci, J., Millet, M.-A., Burel‐Vandenbos, F., Sullivan, T. J., Collins, T. L., Johnson, M. G., Medina, J. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24665 · Cited by 111
Self-citationTargeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma
Huang, J. X., Liu, K., Yu, Y. P., et al. (2012) · Autophagy · doi:10.4161/auto.8.2.18940 · Cited by 111
Bacci, G., Mercuri, M., Briccoli, A., Ferrari, S., Bertoni, F., Donati, D. M., Monti, C., Zanoni, A., Forni, C., & Manfrini, M. (1997) · PubMed · Cited by 109
Epidemiology of osteosarcoma and Ewing's sarcoma in childhood
Buckley, J. D., Pendergrass, T. W., Buckley, C. M., Pritchard, D. J., Nesbit, M. E., Provisor, A. J., & Robison, L. L. (1998) · Cancer · Cited by 103
Interferon Lambda: A New Sword in Cancer Immunotherapy
Lasfar, A., Abushahba, W., Balan, M., & Cohen-Solal, K. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/349575 · Cited by 102
THE SURGICAL TREATMENT AND OUTCOME OF PATHOLOGICAL FRACTURES IN LOCALISED OSTEOSARCOMA
Abudu, A., Sferopoulos, N. K., Tillman, R. M., Carter, S. R., & Grimer, R. J. (1996) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.78b5.0780694 · Cited by 102
Hurley, C., McCarville, M. B., Shulkin, B. L., Mao, S., Wu, J., Navid, F., Daw, N. C., Pappo, A. S., & Bishop, M. W. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26014 · Cited by 100
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · PubMed · doi:10.1002/(sici)1097-4644(199610)63:1%3c37::aid-jcb3%3e3.0.co;2-0 · Cited by 98
The Incidence and Prognosis of Osteosarcoma Skip Metastases
Sajadi, K. R., Heck, R. K., Neel, M. D., Rao, B. N., Daw, N. C., Galindo, C. R., Hoffer, F. A., Stacy, G. S., Peabody, T. D., & Simon, M. A. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000141493.52166.69 · Cited by 97
Buddingh, E. P., Schilham, M. W., Ruslan, S. E. N., Berghuis, D., Szuhai, K., Suurmond, J., Taminiau, A. H. M., Gelderblom, H. A. J., Egeler, R. M., Serra, M., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0965-3 · Cited by 97
Outcome of Treatment for Childhood Cancer in Black as Compared With White Children
Pui, C. (1995) · JAMA · doi:10.1001/jama.1995.03520320043039 · Cited by 96
Height as a Risk Factor for Osteosarcoma
Longhi, A., Pasini, A., Cicognani, A., Baronio, F., Pellacani, A. U. E., Baldini, N., & Bacci, G. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000169251.57611.8e · Cited by 92
Prognostic factors in osteosarcomas. A regression analysis
Bentzen, S. M., Poulsen, H. S., Kaae, S., Jensen, O. M., Johansen, H., Mouridsen, H. T., Daugaard, S., & Arnoldl, C. (1988) · Cancer · doi:10.1002/1097-0142(19880701)62:1<194::aid-cncr2820620129>3.0.co;2-8 · Cited by 92
Takagi, S., Takemoto, A., Takami, M., Oh‐hara, T., & Fujita, N. (2014) · Cancer Science · doi:10.1111/cas.12464 · Cited by 92
Clinicopathologic Features of Osteosarcoma in Patients With Rothmund-Thomson Syndrome
Hicks, J. M., Roth, J. R., Kozinetz, C. A., & Wang, L. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4558 · Cited by 92
Meyers, P. A., & Chou, A. J. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_17 · Cited by 90
Growth and development and other risk factors for osteosarcoma in children and young adults
Gelberg, K. H., Fitzgerald, E., Hwang, S. E., & Dubrow, R. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.272 · Cited by 89
Byun, B. H., Kong, C., Lim, I., Kim, B. I., Choi, C. W., Song, W. S., Cho, W. H., Jeon, D., Koh, J., Lee, S., et al. (2013) · Skeletal Radiology · doi:10.1007/s00256-013-1714-4 · Cited by 88
Arndt, C. A. S., Koshkina, N., Inwards, C. Y., Hawkins, D. S., Krailo, M., Villaluna, D., Anderson, P. M., Goorin, A. M., Blakely, M. L., Bernstein, M. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0662 · Cited by 87
Self-citationOncogene alterations in primary, recurrent, and metastatic human bone tumors
Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D., Pass, H. I., Picci, P., Levine, A. S., & Carbone, M. (1996) · Journal of Cellular Biochemistry · Cited by 87
Webster, T. J., Sun, L., & Chang, K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55505 · Cited by 83
Sulzbacher, I., Birner, P., Trieb, K., Träxler, M., Lang, S., & Chott, A. (2003) · Modern Pathology · doi:10.1097/01.mp.0000043522.76788.0a · Cited by 81
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
Harting, M. T., Lally, K. P., Andrassy, R. J., Vaporciyan, A. A., Cox, C. S., Hayes-Jordan, A. A., & Blakely, M. L. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0690-5 · Cited by 80
Adjuvant chemotherapy of osteosarcoma.
Eilber, F. R., & Rosen, G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.6.982 · Cited by 79
Impact of close surgical margin on local recurrence and survival in osteosarcoma
Li, X., Moretti, V. M., Ashana, A. O., & Lackman, R. D. (2011) · International Orthopaedics · doi:10.1007/s00264-011-1230-x · Cited by 76
Surgical management of adrenal metastases from lung cancer
Beitler, A. L., Urschel, J. D., Velagapudi, S., & Takita, H. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199809)69:1<21::aid-jso5>3.0.co;2-m · Cited by 75
A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families
Porter, D. E., Holden, S., Steel, C., Bb, C., Wallace, M., & Reid, R. (1992) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.74b6.1447251 · Cited by 75
Araki, N., Uchida, A., KIMURA, T., Yoshikawa, H., Aoki, Y., Ueda, T., Takai, S., Miki, T., & Ono, K. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00035 · Cited by 74
A New Approach to the Resection of Pulmonary Osteosarcoma Metastases
Snyder, C. L., Saltzman, D. A., Ferrell, K. L., Thompson, R. C., & Leonard, A. S. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00032 · Cited by 73
Osteosarcoma: Current status of immunotherapy and future trends (Review)
Mori, K., Rédiní, F., Gouin, F., Cherrier, B., & Heymann, D. (2006) · Oncology Reports · doi:10.3892/or.15.3.693 · Cited by 69
COPS3 amplification and clinical outcome in osteosarcoma
Yan, T., Wunder, J. S., Gökgöz, N., Gill, M., Eskandarian, S., Parkes, R. K., Bull, S. B., Bell, R. S., & Andrulis, I. L. (2007) · Cancer · doi:10.1002/cncr.22595 · Cited by 67
(2003) · PubMed · Cited by 67
Worth, L. L., Jia, S.-F., Zhou, Z., Chen, L., & Kleinerman, E. S. (2000) · PubMed · Cited by 65
Self-citationThe patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience
Chi, S. N., Conklin, L. S., Qin, J., Meyers, P. A., Huvos, A. G., Healey, J. H., & Gorlick, R. G. (2003) · Pediatric Blood & Cancer · doi:10.1002/pbc.10420 · Cited by 65
Henriksen, J. M., Ågesen, T. H., Mælandsmo, G. M., Lothe, R. A., Myklebost, O., & Forus, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206671 · Cited by 65
Strategies for the targeted delivery of therapeutics for osteosarcoma
Hughes, D. P. M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903280422 · Cited by 64
Meyers, P. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0_11 · Cited by 64
Patiño‐García, A., Sotillo, E., Díez, M. Z., Iturriagagoitia, L. G., Antillón‐Klussmann, F., & Ariznabarreta, L. S. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200305000-00003 · Cited by 62
miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
Zhou, S., Wang, B., Hu, J. X., Zhou, Y., Jiang, M., Wu, M., Qin, L., & Yang, X. (2016) · Tumor Biology · doi:10.1007/s13277-015-4578-5 · Cited by 62
Bacci, G., Longhi, A., Bertoni, F., Briccoli, A., Versari, M., Pignotti, E., & Picci, P. (2006) · Acta Orthopaedica · doi:10.1080/17453670610013268 · Cited by 59
Late relapse of osteosarcoma: Implications for follow‐up and screening
Strauss, S. J., McTiernan, A., & Whelan, J. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20154 · Cited by 59
Gemoll, T., Epping, F., Heinrich, L., Fritzsche, B., Roblick, U. J., Szymczak, S., Hartwig, S., Depping, R., Bruch, H., Thorns, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4140 · Cited by 56
Ruza, E., Sotillo, E., maga, L. S. U., Azcona, C., & Patiño‐García, A. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200310000-00007 · Cited by 54
Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma
Wang, Z., Qiu, S.-J., Ye, S.-L., et al. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700375 · Cited by 54
Initial Symptoms and Delayed Diagnosis of Osteosarcoma around the Knee Joint
Pan, K. L., Chan, W. H., & Chia, Y. Y. (2010) · Journal of orthopaedic surgery · doi:10.1177/230949901001800112 · Cited by 53
Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas
Goto, A., Kanda, H., Ishikawa, Y., Matsumoto, S., Kawaguchi, N., Machinami, R., Kato, Y., & Kitagawa, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03295.x · Cited by 53
Prediction of Chemotherapy Response by PET-CT in Osteosarcoma
Bajpai, J., Kumar, R., Sreenivas, V., Sharma, M. C., Khan, S. A., Rastogi, S., Malhotra, A., Gamnagatti, S., Kumar, R., Safaya, R., et al. (2011) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31820ff29e · Cited by 53
L??pez-Guerrero, J. A., L??pez-Gin??s, C., Pell??n, A., Cardá, C., & Llombart‐Bosch, A. (2004) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200406000-00004 · Cited by 52
Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis
Zandueta, C., Ormazabal, C., Perurena, N., Martínez-Canarias, S., Zalacaín, M., San-Julián, M., Grigoriadis, A. E., Valencia, K., Campos-Laborie, F. J., Rivas, J. D. L., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4740 · Cited by 51
Guma, S. R., Lee, D. A., Yu, L., Gordon, N. B., Hughes, D. P. M., Stewart, J., Wang, W., & Kleinerman, E. S. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24801 · Cited by 50
Self-citationKudawara, I., Aoki, Y., Ueda, T., Araki, N., Naka, N., Nakanishi, H., Matsumine, A., Ieguchi, M., Mori, S., Myoui, A., et al. (2013) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000055 · Cited by 50
Skip metastases in osteosarcoma: Recent experience
Malawer, M. M., & Dunham, W. K. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930220406 · Cited by 49
An Assessment of Bone Fluoride and Osteosarcoma
Kim, F. M., Hayes, C., Williams, P. L., Whitford, G. M., JOSHIPURA, K. J., Hoover, R. N., Douglass, C. W., the National Osteosarcoma Etiology Group, Gebhardt, M. C., Scarborough, M. T., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034511418828 · Cited by 46
Strategies and developments of immunotherapies in osteosarcoma
WAN, J., Zhang, X., Liu, T., & Zhang, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3962 · Cited by 46
Improved survival in children with osteosarcoma following resection of pulmonary metastases
Schaller, R. T., Haas, J., Schaller, J. F., Morgan, A., & Bleyer, A. (1982) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(82)80106-1 · Cited by 44
The Retinoblastoma Protein in Osteoblast Differentiation and Osteosarcoma
Deshpande, A., & Hinds, P. W. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070809 · Cited by 43
Levy, M., & Leclerc, B. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.11.008 · Cited by 42
Bajpai, J., Kumar, R., Sreenivas, V., Sharma, M. C., Khan, S. A., Rastogi, S., Malhotra, A., Gamnagatti, S., Kumar, R., Safaya, R., et al. (2011) · PubMed · doi:10.1097/mph.0b013e31820ff78e · Cited by 42
Guma, S. R., Lee, D. A., Yu, L., Gordon, N. B., & Kleinerman, E. S. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25019 · Cited by 40
Self-citationStokkel, M. P. M., Linthorst, M., Borm, J. J. J., Taminiau, A., & Pauwels, E. J. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-002-0350-5 · Cited by 36
Biteau, K., Guiho, R., Chatelais, M., Taurelle, J., Chesneau, J., Corradini, N., Heymann, D., & Rédiní, F. (2016) · PubMed · Cited by 36
Relationship between height at diagnosis and bone tumours in young people: a meta-analysis
Arora, R. S., Kontopantelis, E., Alston, R. D., Eden, T. O. B., Geraci, M., & Birch, J. M. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9740-9 · Cited by 34
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma
Ouyang, Z., Li, H., Zhai, Z., Xu, J., Dass, C. R., Qin, A., & Dai, K. (2018) · Current Drug Targets · doi:10.2174/1573399811666150615145409 · Cited by 32
Kumar, R. M. R., Arlt, M., Kuzmanov, A., Born, W., & Fuchs, B. (2015) · Europe PMC (PubMed Central) · doi:10.5167/uzh-117024 · Cited by 32
Hereditary Retinoblastoma: Host Resistance and Second Primary Tumors 2 3
Matsunaga, E. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/65.1.47 · Cited by 30
Gandhi, D., Naoghare, P. K., Bafana, A., Krishnamurthi, K., & Sivanesan, S. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0756-6 · Cited by 30
Jeon, D., Song, W. S., Kong, C., Cho, W. H., Cho, S. H., Lee, J. D., & Lee, S. (2013) · Clinics in Orthopedic Surgery · doi:10.4055/cios.2013.5.3.216 · Cited by 24
SEOM clinical guidelines for the treatment of osteosarcoma in adults-2013
Redondo, A., Cruz, J. J., Pousa, A. L., & Barón, F. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1087-0 · Cited by 22
Fluoride exposure in public drinking water and childhood and adolescent osteosarcoma in Texas
Archer, N. P., Napier, T. S., & Villanacci, J. F. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0759-9 · Cited by 21
He, J., ZHANG, P., Li, Q., Zhou, D., & Liu, P. (2015) · Oncology Letters · doi:10.3892/ol.2015.3907 · Cited by 19
Marina, N. M., Smeland, S., Bielack, S., Bernstein, M. R., Jovic, G., Hook, J., Krailo, M. D., Butterfaß‐Bahloul, T., Kühne, T., Eriksson, M., et al. (2014) · UCL Discovery (University College London) · Cited by 15
THE SURGICAL TREATMENT AND OUTCOME OF PATHOLOGICAL FRACTURES IN LOCALISED OSTEOSARCOMA
Abudu, A., Sferopoulos, N. K., & Tillman, E. A. R. M. (1997) · Journal of Pediatric Orthopaedics · doi:10.1097/00004694-199703000-00064 · Cited by 11
Zeidner, J. F., Gladstone, D. E., ZAHURAK, M. L., Matsui, W. H., Gocke, C. D., Jones, R. J., & Smith, B. D. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.05.012 · Cited by 11
McTiernan, A., Meyer, T., Michelagnoli, M. P., Lewis, I. J., & Whelan, J. S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20562 · Cited by 11
Lussier, D. M., Johnson, J. L., Hingorani, P., & Blattman, J. N. (2015) · Cancer Immunology Research · doi:10.1158/2326-6074.tumimm14-a07 · Cited by 2
Cited by
Molecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Zhou, Y., Slone, N., Chrisikos, T. T., Kyrysyuk, O., Babcock, R. L., Medik, Y. B., Li, H. S., Kleinerman, E. S., & Watowich, S. S. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000474 · Cited by 112
Self-citationFan, T. M., Roberts, R. D., & Lizardo, M. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00013 · Cited by 90
Aran, V., Devalle, S., Meohas, W., Heringer, M., Cunha Caruso, A., Pinheiro Aguiar, D., Leite Duarte, M. E., & Moura Neto, V. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103340 · Cited by 87
Navet, B., Ando, K., Vargas-Franco, J. W., Brion, R., Amiaud, J., Mori, K., Yagita, H., Mueller, C. G., Verrecchia, F., Dumars, C., et al. (2018) · Cancers · doi:10.3390/cancers10110398 · Cited by 52
Metadata
- Authors
- Lindsey, B. A., Markel, J. E., & Kleinerman, E. S.
- Venue
- Rheumatology and Therapy
- Published
- 2016-12-08
- Volume
- 4
- Issue
- 1
- Pages
- 25-43
- ISSN
- 2198-6576 (ISSN-L)
- 2198-6584
- OpenAlex
- W3191998012
- Cited by
- 487
- References
- 184
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.